AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
AnGes Research and Development Expense (Quarterly): 6.546M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.546M |
| December 31, 2023 | 9.032M |
| September 30, 2023 | 11.60M |
| June 30, 2023 | 11.55M |
| March 31, 2023 | 11.96M |
| December 31, 2022 | 17.53M |
| September 30, 2022 | 13.83M |
| June 30, 2022 | 33.57M |
| March 31, 2022 | 19.52M |
| December 31, 2021 | 20.17M |
| September 30, 2021 | 32.06M |
| June 30, 2021 | 23.26M |
| March 31, 2021 | 22.81M |
| December 31, 2020 | 18.34M |
| September 30, 2020 | 7.311M |
| June 30, 2020 | 4.428M |
| March 31, 2020 | 5.770M |
| December 31, 2019 | 5.772M |
| September 30, 2019 | 4.263M |
| June 30, 2019 | 3.971M |
| March 31, 2019 | 6.300M |
| December 31, 2018 | 7.895M |
| September 30, 2018 | 7.590M |
| June 30, 2018 | 3.676M |
| March 31, 2018 | 3.715M |
| Date | Value |
|---|---|
| December 31, 2017 | 3.698M |
| September 30, 2017 | 7.128M |
| June 30, 2017 | 4.649M |
| March 31, 2017 | 7.698M |
| December 31, 2016 | 9.131M |
| September 30, 2016 | 7.649M |
| June 30, 2016 | 13.13M |
| March 31, 2016 | 8.602M |
| December 31, 2015 | 7.810M |
| September 30, 2015 | 7.146M |
| June 30, 2015 | 7.837M |
| March 31, 2015 | 6.381M |
| December 31, 2014 | 5.506M |
| September 30, 2014 | 8.587M |
| June 30, 2014 | 4.460M |
| March 31, 2014 | 3.510M |
| December 31, 2013 | 3.025M |
| September 30, 2013 | 1.976M |
| June 30, 2013 | 3.005M |
| March 31, 2013 | 2.483M |
| December 31, 2012 | 2.938M |
| September 30, 2012 | 2.874M |
| June 30, 2012 | 5.193M |
| March 31, 2012 | 4.030M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.971M
Minimum
Jun 2019
33.57M
Maximum
Jun 2022
14.16M
Average
11.78M
Median
Research and Development Expense (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.320B |
| Nxera Pharma Co Ltd | 21.31M |
| PeptiDream Inc | 4.654M |
| Healios KK | 4.602M |
| SanBio Co Ltd | 2.750M |